Unicharm (OTCMKTS:UNICY – Get Free Report) and Beauty Health (NASDAQ:SKIN – Get Free Report) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.
Profitability
This table compares Unicharm and Beauty Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Unicharm | 6.65% | 7.19% | 5.28% |
| Beauty Health | -9.79% | -47.83% | -5.79% |
Valuation and Earnings
This table compares Unicharm and Beauty Health”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Unicharm | $6.32 billion | 1.68 | $436.93 million | $0.13 | 23.43 |
| Beauty Health | $300.80 million | 0.29 | -$9.52 million | ($0.22) | -3.07 |
Unicharm has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Unicharm, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
93.3% of Beauty Health shares are owned by institutional investors. 35.5% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Volatility and Risk
Unicharm has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Unicharm and Beauty Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Unicharm | 0 | 2 | 0 | 0 | 2.00 |
| Beauty Health | 1 | 5 | 1 | 0 | 2.00 |
Beauty Health has a consensus target price of $1.38, indicating a potential upside of 103.70%. Given Beauty Health’s higher possible upside, analysts clearly believe Beauty Health is more favorable than Unicharm.
Summary
Unicharm beats Beauty Health on 8 of the 13 factors compared between the two stocks.
About Unicharm
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand. It also provides masks under the Unicharm brand; home care products, including cleaning sheets under the Wave brand name; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand name. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Aiken Genki, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, and Neko Genki brands; and deodorizing beads. Further, it is involved in the manufacture and sale of industrial materials related products, etc., as well as food-packaging materials. Unicharm Corporation was incorporated in 1941 and is headquartered in Tokyo, Japan.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Receive News & Ratings for Unicharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unicharm and related companies with MarketBeat.com's FREE daily email newsletter.
